• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂质体在感染治疗中的应用。

Liposomes in the treatment of infections.

作者信息

Bakker-Woudenberg I A, Storm G, Woodle M C

机构信息

Dept. Clinical Microbiology, Erasmus University Rotterdam, The Netherlands.

出版信息

J Drug Target. 1994;2(5):363-71. doi: 10.3109/10611869408996811.

DOI:10.3109/10611869408996811
PMID:7704480
Abstract

The use of liposomes in the treatment of severe infections is under investigation. Classical liposomes which localize in cells of the mononuclear phagocyte system (MPS) can be exploited in two ways. First for targeting of macrophage modulators such as muramyl peptides or IFN-gamma, to stimulate the cells of the MPS to maximal blood clearance capacity. This enhanced nonspecific anti-infectious resistance is important as in immunocompromised patients micro-organisms frequently appear in the blood from a local infection. Secondly, classical liposomes are successfully used as carriers of antibiotics in experimental intracellular parasitic-, viral-, fungal- or bacterial infections in MPS tissues. Based on these data extensive studies in patients with severe fungal infections have demonstrated successful treatment with liposomal or lipid-complexed amphotericin B. More recently, liposomal amphotericin B appeared to be effective in patients with drug-resistant visceral leishmaniasis. For the treatment of Mycobacterium avium complex infection in AIDS patients the efficacy of liposomal gentamicin is under investigation. With respect to infections in non-MPS tissues the applicability of Stealth liposomes characterized by long circulation half-lives is under investigation. Substantial localization of these liposomes in infected lung tissue of rats was demonstrated. Preliminary data in experimental bacterial lung infection showed superior efficacy of antibiotic encapsulated in Stealth liposomes.

摘要

脂质体在严重感染治疗中的应用正在研究中。定位于单核吞噬细胞系统(MPS)细胞的传统脂质体可通过两种方式加以利用。其一,用于靶向巨噬细胞调节剂,如胞壁酰肽或干扰素-γ,以刺激MPS细胞达到最大的血液清除能力。这种增强的非特异性抗感染抵抗力很重要,因为在免疫受损患者中,微生物常常从局部感染进入血液。其二,在MPS组织的实验性细胞内寄生虫、病毒、真菌或细菌感染中,传统脂质体成功用作抗生素的载体。基于这些数据,对严重真菌感染患者进行的广泛研究已证明,脂质体或脂质复合两性霉素B治疗成功。最近,脂质体两性霉素B在耐药内脏利什曼病患者中似乎有效。对于艾滋病患者鸟分枝杆菌复合感染的治疗,脂质体庆大霉素的疗效正在研究中。关于非MPS组织中的感染,具有长循环半衰期特征的隐形脂质体的适用性正在研究中。已证明这些脂质体在大鼠感染的肺组织中有大量定位。实验性细菌性肺部感染的初步数据显示,隐形脂质体包裹的抗生素疗效更佳。

相似文献

1
Liposomes in the treatment of infections.脂质体在感染治疗中的应用。
J Drug Target. 1994;2(5):363-71. doi: 10.3109/10611869408996811.
2
Liposomes and lipid carriers in the treatment of microbial infections.脂质体和脂质载体在微生物感染治疗中的应用。
Scand J Infect Dis Suppl. 1990;74:34-41.
3
Long-circulating sterically stabilized liposomes in the treatment of infections.长效循环空间稳定脂质体在感染治疗中的应用
Methods Enzymol. 2005;391:228-60. doi: 10.1016/S0076-6879(05)91014-8.
4
Doxorubicin entrapped in sterically stabilized liposomes: effects on bacterial blood clearance capacity of the mononuclear phagocyte system.包封于空间稳定脂质体中的阿霉素:对单核吞噬细胞系统细菌血清除能力的影响
Clin Cancer Res. 1998 Jan;4(1):111-5.
5
Therapeutic efficacy of liposome-encapsulated gentamicin in rat Klebsiella pneumoniae pneumonia in relation to impaired host defense and low bacterial susceptibility to gentamicin.脂质体包裹庆大霉素对大鼠肺炎克雷伯菌肺炎的治疗效果与宿主防御功能受损及细菌对庆大霉素低敏感性的关系
Antimicrob Agents Chemother. 2001 Feb;45(2):464-70. doi: 10.1128/AAC.45.2.464-470.2001.
6
The role of liposomal amphotericin B in the treatment of systemic fungal infections.
Eur J Cancer Clin Oncol. 1989;25 Suppl 2:S63-8.
7
Treatment of experimental osteomyelitis by liposomal antibiotics.脂质体抗生素治疗实验性骨髓炎
J Antimicrob Chemother. 2004 Dec;54(6):1103-8. doi: 10.1093/jac/dkh465. Epub 2004 Oct 14.
8
Stavudine-loaded mannosylated liposomes: in-vitro anti-HIV-I activity, tissue distribution and pharmacokinetics.载有司他夫定的甘露糖化脂质体:体外抗HIV-1活性、组织分布及药代动力学
J Pharm Pharmacol. 2006 May;58(5):605-16. doi: 10.1211/jpp.58.5.0005.
9
Liposomal amphotericin B as first line and secondary prophylactic treatment for visceral leishmaniasis in a patient infected with HIV.脂质体两性霉素B作为一名感染HIV患者内脏利什曼病的一线及二线预防性治疗药物。
Ann Ital Med Int. 2000 Apr-Jun;15(2):169-71.
10
Stealth liposomes: an improved sustained release system for 1-beta-D-arabinofuranosylcytosine.隐形脂质体:一种用于1-β-D-阿拉伯呋喃糖基胞嘧啶的改进型缓释系统。
Cancer Res. 1992 May 1;52(9):2431-9.

引用本文的文献

1
Advantages and Limitations of Current Imaging Techniques for Characterizing Liposome Morphology.当前用于表征脂质体形态的成像技术的优势与局限
Front Pharmacol. 2018 Feb 6;9:80. doi: 10.3389/fphar.2018.00080. eCollection 2018.
2
Enhanced antitumor immunity of nanoliposome-encapsulated heat shock protein 70 peptide complex derived from dendritic tumor fusion cells.源自树突状肿瘤融合细胞的纳米脂质体包裹热休克蛋白70肽复合物增强抗肿瘤免疫
Oncol Rep. 2015 Jun;33(6):2695-702. doi: 10.3892/or.2015.3934. Epub 2015 Apr 27.
3
Oleanolic acid liposomes with polyethylene glycol modification: promising antitumor drug delivery.
聚乙二醇修饰的齐墩果酸脂质体:有前途的抗肿瘤药物递送系统。
Int J Nanomedicine. 2012;7:3517-26. doi: 10.2147/IJN.S31725. Epub 2012 Jul 6.
4
Biophysical studies on chitosan-coated liposomes.壳聚糖包被脂质体的生物物理研究。
Eur Biophys J. 2009 Oct;38(8):1127-33. doi: 10.1007/s00249-009-0524-z. Epub 2009 Aug 2.
5
Liposomal drug formulations. Rationale for development and what we can expect for the future.脂质体药物制剂。开发原理及我们对未来的期望。
Drugs. 1998 Nov;56(5):747-56. doi: 10.2165/00003495-199856050-00001.
6
Rationale for and efficacy of prolonged-interval treatment using liposome-encapsulated amikacin in experimental Mycobacterium avium infection.脂质体包裹的阿米卡星延长间隔治疗在实验性鸟分枝杆菌感染中的原理及疗效
Antimicrob Agents Chemother. 1998 Feb;42(2):459-61. doi: 10.1128/AAC.42.2.459.